ArticleInternational urogynecology journal2026
Sacral and Bladder Stimulation Synergistically Treat Post-Stroke Urgency Incontinence.
Article in International urogynecology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
introduction and hypothesisTo evaluate the clinical efficacy and safety of combined sacral magnetic stimulation (SMS) and bladder electrical stimulation (ES) in treating post-stroke urgency urinary incontinence (UUI).
methodsWe retrospectively enrolled 90 patients with post-stroke UUI, divided into ES, SMS, and SMS + ES groups (n = 30 each). Urodynamic parameters, voiding diaries, quality of life scales (ICIQ-SF, ICIQ-QoL, SAS), Patient Global Impression of Improvement (PGI-I), urinary tract infection (UTI) incidence, and overall response rates were compared before and 1 month after treatment.
resultsThe SMS + ES group demonstrated comprehensive therapeutic advantages. Urodynamically, this group showed significantly greater maximum bladder capacity (408.5 ± 70.1 mL), lower postvoid residual urine volume (75.2 ± 53.4 mL), and lower detrusor pressure at maximum flow (28.4 ± 6.5 cmH
conclusionCombined SMS and ES therapy synergistically improves storage and voiding function, alleviates anxiety, reduces UTI risk, and significantly enhances quality of life in post-stroke UUI patients, demonstrating superior efficacy over either therapy alone.
Indexed as
Identifiers
41579190What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.